Skip to main content

Trio-Tech Resumes Operations at Tianjin City Facility

Trio-Tech International (NYSE MKT: TRT) today announced that it has resumed full operations at the Company’s Tianjin, China, facility.

S.W. Yong, Trio-Tech’s CEO, said, “On Thursday, January 20, the Tianjin City Government removed the lockdown measures and we commenced resuming operations at our facility. By Friday, January 21, 2022, our Tianjin operations achieved 100% operating capacity. We are actively working on our production output to catch up with backlog.”

“Trio-Tech Tianjin was in full cooperation with the lockdown mandate imposed by the Tianjin City Government and we are resuming operations cautiously with stringent health and safety measures as required by the local government mandate. Throughout the lockdown, our primary concern has been the safety of our employees, customers, suppliers and the Tianjin community as a whole. We expect to continue working closely with local authorities to achieve safe, long-term, COVID-19 compliant operations consistent with the needs of the Tianjin City authorities,” added Mr. Yong.

About Trio-Tech

Established in 1958, Trio-Tech International is located in Van Nuys, California, with its Principal Executive Office and regional headquarter in Singapore. Trio-Tech International is a diversified business group with interests in semiconductor testing services, manufacturing and distribution of semiconductor testing equipment, and real estate. Our subsidiary locations include Tianjin, Suzhou, Chongqing in China, as well as Kuala Lumpur Malaysia and Bangkok Thailand. Further information about Trio-Tech's semiconductor products and services can be obtained from the Company's Web site at www.triotech.com and www.universalfareast.com.

Contacts

Company Contact:

A. Charles Wilson

Chairman

(818) 787-7000

Investor Contact:

Berkman Associates

(310) 927-3108

robert.jacobs@jacobscon.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.